Literature DB >> 25934299

NICE CG178 Psychosis and Schizophrenia in Adults: Treatment and Management - an evidence-based guideline?

Mark Taylor1, Udayanga Perera1.   

Abstract

National Institute for Health and Care Excellence (NICE) clinical guideline (CG)178 was published in 2014. NICE guidelines occupy an important international position. We argue that CG178 overemphasises the use of cognitive-behavioural therapy for schizophrenia and those 'at risk' of psychosis, with recommendations that do not always reflect the evidence base. The CG178 recommendations on medications are limited. © The Royal College of Psychiatrists 2015.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25934299     DOI： 10.1192/bjp.bp.114.155945

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  15 in total

1.  Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.

Authors:  Cathy Davies; Andrea Cipriani; John P A Ioannidis; Joaquim Radua; Daniel Stahl; Umberto Provenzani; Philip McGuire; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

2.  Do adjunctive art therapies reduce symptomatology in schizophrenia? A meta-analysis.

Authors:  Keith R Laws; William Conway
Journal:  World J Psychiatry       Date:  2019-12-19

3.  Mandatory implementation of NICE Guidelines for the care of bipolar disorder and other conditions in England and Wales.

Authors:  Richard Morriss
Journal:  BMC Med       Date:  2015-09-30       Impact factor: 8.775

4.  Change in the Neural Response to Auditory Deviance Following Cognitive Therapy for Hallucinations in Patients With Schizophrenia.

Authors:  Verner Knott; Nicola Wright; Dhrasti Shah; Ashley Baddeley; Hayley Bowers; Sara de la Salle; Alain Labelle
Journal:  Front Psychiatry       Date:  2020-06-12       Impact factor: 4.157

5.  Cognitive Behavioural Therapy for schizophrenia - outcomes for functioning, distress and quality of life: a meta-analysis.

Authors:  Keith R Laws; Nicole Darlington; Tejinder K Kondel; Peter J McKenna; Sameer Jauhar
Journal:  BMC Psychol       Date:  2018-07-17

6.  Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review.

Authors:  Chiara Gastaldon; Franziska Mosler; Sarah Toner; Federico Tedeschi; Victoria Jane Bird; Corrado Barbui; Stefan Priebe
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

7.  Comparison of clozapine monitoring and adverse event management in a psychiatrist-only and a clinical pharmacist-psychiatrist collaborative clinic.

Authors:  Samantha Maryan; Michelle Harms; Erin McAllister; Beth DeJongh
Journal:  Ment Health Clin       Date:  2019-03-01

8.  A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach.

Authors:  Mattia Veronese; Barbara Santangelo; Sameer Jauhar; Enrico D'Ambrosio; Arsime Demjaha; Hugh Salimbeni; Jin Huajie; Paul McCrone; Federico Turkheimer; Oliver Howes
Journal:  Neuropsychopharmacology       Date:  2020-09-22       Impact factor: 7.853

9.  Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register.

Authors:  Rudolf N Cardinal; George Savulich; Louisa M Mann; Emilio Fernández-Egea
Journal:  NPJ Schizophr       Date:  2015-10-21

10.  Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.

Authors:  Anthony P Morrison; Heather Law; Lucy Carter; Rachel Sellers; Richard Emsley; Melissa Pyle; Paul French; David Shiers; Alison R Yung; Elizabeth K Murphy; Natasha Holden; Ann Steele; Samantha E Bowe; Jasper Palmier-Claus; Victoria Brooks; Rory Byrne; Linda Davies; Peter M Haddad
Journal:  Lancet Psychiatry       Date:  2018-04-05       Impact factor: 27.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.